Clinical Trial Update: Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

View source ↗

Summary

This clinical trial evaluates the relationship between C1q binding to HLA antibodies (measured in a solid-phase immunoassay) and the clinical effect on platelet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platelet Transfusion Refractoriness
• Thrombocytopenia

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Thrombocytopenia, Platelet Transfusion Refractoriness | Status: COMPLETED